Freshfields Bruckhaus Deringer and Mayer Brown advised Charterhouse Capital Partners LLP on the deal and McDermott advised Labelium. Charterhouse Capital Partners LLP entered into an agreement...
Charterhouse Capital Partners’ Investment in Labelium
uniQure’s Acquisition of Corlieve Therapeutics
McDermott Will & Emery has advised Corlieve Therapeutics, while Morgan Lewis has advised uniQure on the deal. Corlieve Therapeutics completed its sale to uniQure, with its...